Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ACIDE FUSIDIQUE MYLAN 2 % (acide fusidique)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ACIDE FUSIDIQUE MYLAN 2 % (acide fusidique)

Medicine - Posted on Nov 17 2021
Active substance (DCI)
  • acide fusidique
history (1)
  • 10/13/21

    ACIDE FUSIDIQUE MYLAN (acide fusidique) - Infections cutanées

    Réévaluation. L'essentiel Avis favorable au remboursement dans les indications de l’AMM. Service médical rendu désormais fai...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • Formes topiques : D06AX01
Manufacturer
MYLAN
Presentation

ACIDE FUSIDIQUE MYLAN 2 %, crème
1 tube aluminium de 15 g (CIP : 34009 388 757 0 6)

All our publications
    Bacterial infections Drug therapy Paediatrics Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
XsQKbh9nyHgLwQAP